EKF Diagnostics Holdings (EKF)

Sector:

Financials

Index:

FTSE AIM All-Share

28.50p
   
  • Change Today:
      0.20p
  • 52 Week High: 31.00
  • 52 Week Low: 18.75
  • Currency: UK Pounds
  • Shares Issued: 449.09m
  • Volume: 25,443
  • Market Cap: £127.99m
  • Beta: 0.01

EKF Overview

EKF Diagnostics is a global medical manufacturer of point-of-care and central lab devices and chemistry reagents including hemoglobin tests, HbA1c tests, glucose and lactate tests.
Competitors: Physiomics, SDI Group , Polarean Imaging
Registrars: Capita Registrars

Key Personnel

CEO: Gavin T Jones
CFO: Stephen (Steve) Young
Executive Chairman: Julian Baines
Senior Independent Director: Christian Alexander Rigg
Non-Executive Dir: Jenny Winter, Christopher H B Mills

Contact Details

Address: Avon House, 19 Stanwell Road, Penarth, Cardiff, United Kingdom, CF64 2EZ
Phone: +44 (0)29 20 710570
Fax: +44 (0)29 20 705715
Website: http://www.ekfdiagnostics.com

Listings

Sector: Financials(LSE)
Index: FTSE AIM All-Share
ISIN: GB0031509804

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

EKF Market Data

Currency UK Pounds
Share Price 28.50p
Change Today 0.20p
% Change 0.71 %
52 Week High 31.00
52 Week Low 18.75
Volume 25,443
Shares Issued 449.09m
Market Cap £127.99m
Beta 0.01

EKF Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
90.78% below the market average90.78% below the market average90.78% below the market average90.78% below the market average90.78% below the market average
85.86% below the sector average85.86% below the sector average85.86% below the sector average85.86% below the sector average85.86% below the sector average
Price Trend
25.66% above the market average25.66% above the market average25.66% above the market average25.66% above the market average25.66% above the market average
3.92% below the sector average3.92% below the sector average3.92% below the sector average3.92% below the sector average3.92% below the sector average
Income Not Available
Growth
60.76% above the market average60.76% above the market average60.76% above the market average60.76% above the market average60.76% above the market average
57.45% above the sector average57.45% above the sector average57.45% above the sector average57.45% above the sector average57.45% above the sector average

What The Brokers Say

Strong Buy 1
Buy 3
Neutral 0
Sell 0
Strong Sell 0
Total 4
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

EKF Dividends

  Latest Previous
  Final Final
Ex-Div 02-Nov-23 03-Nov-22
Paid 01-Dec-23 01-Dec-22
Amount 1.20p 1.20p

Trades for 07-Aug-2025

Time Volume / Share Price
12:46 5 @ 28.50p
10:21 20,313 @ 29.50p
08:00 125 @ 30.00p
08:00 5,000 @ 28.66p

EKF Key Personnel

CFO Stephen (Steve) Young
CEO Gavin T Jones

Top of Page